Sutro Biopharma, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
STRO Nasdaq 2836 www.sutrobio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sutro Biopharma, Inc.

Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million - May 31st, 2026 8:39 am
Barclays initiates oncology-focused biotechs with positive outlook - May 28th, 2026 9:26 am
News Flash: Analysts Just Made A Massive Upgrade To Their Sutro Biopharma, Inc. (NASDAQ:STRO) Forecasts - May 28th, 2026 5:19 am
US$47.10 - That's What Analysts Think Sutro Biopharma, Inc. (NASDAQ:STRO) Is Worth After These Results - May 17th, 2026 7:02 am
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights - May 14th, 2026 2:05 pm
MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates - May 6th, 2026 4:30 pm
Ocugen (OCGN) Reports Q1 Loss, Beats Revenue Estimates - May 5th, 2026 8:00 am
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program - May 1st, 2026 2:17 am
Meta downgraded, Qualcomm upgraded: Wall Street's top analyst calls - Apr 30th, 2026 7:36 am
Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right Now - Apr 29th, 2026 11:00 am
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 - Apr 19th, 2026 5:45 pm
Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last? - Apr 8th, 2026 6:31 am
Arm downgraded, Arista Networks upgraded: Wall Street's top analyst calls - Apr 7th, 2026 7:47 am
Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains? - Apr 1st, 2026 1:19 am
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights - Mar 23rd, 2026 2:05 pm
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates - Mar 3rd, 2026 3:10 pm
Sutro Biopharma to Participate in Upcoming Investor Conferences - Feb 25th, 2026 6:30 am
Sutro Biopharma Announces Participation at the 16th World ADC London Summit - Feb 23rd, 2026 6:30 am
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains? - Feb 11th, 2026 5:25 am
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering - Feb 10th, 2026 5:00 am